Another Magic Drug to treat near vision defect or Presbyopia,an Eye drop by ‘Entod Pharmaceuticals’ “PresVu” is in market India permitted by Drug controller of India.Company is all set to earn thousand crores by huge advertisements But how it will perform this in just 15 Minutes,neither company nor Drug Controller office release details.During Corona,people lost their hard earn money and Drug Companies earned billions by Corona Vaccines and Medicines which are today discarded and even sued in USA.Will our Ministry of health & Chemicals fertilisers dealing pharma act to press DCI/Company to furnish details or our Ministry of IB will act to stop advertising Miracle drugs in name of Drug Controller license to earn thousand crores without furnishing detailsas few ayurvedic eye drops as Isotine or Drishti earning crores.
Presbyopia or farsightedness is the gradual loss of our eye’s ability to focus on near by or close objects or read writings.It is natura and affects All ,Male & Female.It is noticed near age of 40 and continues to worsen till age of 65 yrs.It occurs as our eye natural lens grows less flexible or elastic with aging so hampers it’s ability to change it’s focus as shown in images.
The treatment is designed in the way that it compensate to our eye to focus on near by objects which is till today achieved by wearing eye glasses or specs before Eyes or near vision glasses or by contact lens inside eye over cornea or by refractive surgery or by lens implants.If cataract present then by removal of lens and implantation of lens if cataract matures.
The Myopia or nearsightedness where person can’t see distant objects may occur at any age even from early childhood requiring wearing of high power glasses or correcting cornea curvature by Diamond knife or popular Laser reflective surgery whether this will be treated by this drop,Drug controller or company said nothing.
Entod Pharmaceuticals’ PresVu eye drops,has already received approval for the eye drop from the Subject Expert Committee of the Central Drugs Standard Control Organization (CDSCO).
Speaking about PresVu, Nikhil K Masurkar, CEO, Entod Pharmaceuticals, said, “PresVu has been created through years of research and development.” Its approval by DCGI is a major step in our mission to transform eye care in India.
Entod Pharmaceuticals has applied for a patent regarding the formulation and process of PresVu
In India,an “isotine eye drop” developed by ayurvedic physician Dr M S Basu which treat variety of eye diseases as redness.burning,irritation,eye sickness,allergies and corrects Vision.Same way “Drishti eye drop” developed by Swami Ramdeo’s Patanjali.
Both companies put advertisemens of crores in print or digital media and TVs to sell these drops earing thousand crores since inception by mostly making claims by their own research designed and tested solely by them or their associates but never a double or triple blind reasearch which is mandatory to launch a Medical product in world with regular observing it’s benefit or side effects by continuing prospective or retrospective studies.They sell by huge advertisements in TVs/Net/Social Media shows and in print media.Ayurvedic Controller or department never governs their efficacy effectively during their launch what to talk of fututr checks.
As tablet coronil sold in crores by Ramdeo ji to earn Crores on false claim.
Highlighting the benefits of PresVu for patients, Dr Aditya Sethi noted that The formula uses advanced dynamic buffer technology to rapidly adapt to the pH of tears. He added that Presbyopia can be treated effectively as the eye drop improves near vision within 15 minutes.
Commenting on the clinical potential of PresVu, Dr Dhananjay Bakhle said for presbyopia patients, this eye drop provides a non-invasive option that eliminates the need for reading glasses.
Such claims although cleared by Drug controller of India still raise question in mind of people as by simple lubrication and so called ph correction how a structural and physiological change developing in elasticity of lens over many years of aging can be corrected by a drop in eye in just 15 minutes which till today need wearing of glasses or surgical correction only if cataract which is separate disease.
Our health Ministry dealing both modern medicine and Ayurved should investigate these claims and should give full details of functioning to educate our people keeping details of such claims or researches in public before this company earn thousand crores by big advertisements as so many pharma companies earned in name of corona medicines and vaccines.
Our information and broadcasting Ministry should wake up sothat such advertisements are checked fully and are placed in total before [ublic rather to highlight it’s benefit only on their claims,omitting every limitation in the name of approval by drug Controller of India.
